EyeGate Pharma Hits Primary Endpoint in PRK Pivotal Study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/10/2026

1. SKHY
2. USO
3. SPY
4. META
5. DAL
6. PEP
7. ALP
8. SKHYV
9. NVDA
10. NRIX

Go back to EyeGate Pharma Hits Primary Endpoint in PRK Pivotal Study
(NASDAQ: EYEG) Delayed: 34.88 -0.07 (0.2%)
Previous Close $34.95    52 Week High $5.09 
Open $34.88    52 Week Low $1.11 
Day High $34.88    P/E N/A 
Day Low $34.88    EPS $0.00 
Volume 20